Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Outline of Final Research Achievements |
Local anesthetic, bupivacaine, is known to have neurotoxicity. Bupivacaine decreased viability of human neuroblastoma cell line (SH-SY5Y cell). T-type calcium channel blocker exacerbated the bupivacaine induced cell death. According to the result of realtime PCR, Cav3.1 was the only subtype of T-type calcium channel which expressed on the SH-SY5Y cell.
|